Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume

ABSTRACT:

SUBMITTER: Locke F 

PROVIDER: S-EPMC11208295 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature